Advertisement
Australia markets closed

  • ALL ORDS

    8,022.70
    +28.50 (+0.36%)
     

  • ASX 200

    7,749.00
    +27.40 (+0.35%)
     

  • AUD/USD

    0.6604
    -0.0017 (-0.26%)
     

  • OIL

    78.20
    -1.06 (-1.34%)
     

  • GOLD

    2,366.90
    +26.60 (+1.14%)
     

  • Bitcoin AUD

    91,942.72
    -3,887.73 (-4.06%)
     

  • CMC Crypto 200

    1,256.70
    -101.31 (-7.46%)
     

  • AUD/EUR

    0.6128
    -0.0010 (-0.16%)
     

  • AUD/NZD

    1.0963
    -0.0006 (-0.05%)
     

  • NZX 50

    11,755.17
    +8.59 (+0.07%)
     

  • NASDAQ

    18,161.18
    +47.72 (+0.26%)
     

  • FTSE

    8,433.76
    +52.41 (+0.63%)
     

  • Dow Jones

    39,512.84
    +125.08 (+0.32%)
     

  • DAX

    18,772.85
    +86.25 (+0.46%)
     

  • Hang Seng

    18,963.68
    +425.87 (+2.30%)
     

  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     

How one founder saw the value of remote care for addiction treatment long before the pandemic

Darrell Etherington
Updated ·1-min read

Yusuf Sherwani saw the value in remote mental healthcare long before COVID sent everyone into video therapy sessions. He is the CEO and one of three doctor/co-founders of Quit Genius, an app that uses CBT therapy and other proven methods to help patients tackle their addiction. He talks with Darrell and Jordan about starting a telehealth company before COVID and the regulatory hurdles they had to navigate and how they convinced investors that it was crucial to be research-led when it comes to building a patient-focused product.

Take our listener survey and let us know a bit about yourself and what you think of FOUND.

Connect with us: